期刊文献+

小剂量^131I治疗青少年Graves’病85例患者疗效观察

The observation of curative effects by therapy with low-dose ^131I in younger with Graves' disease
原文传递
导出
摘要 目的探讨小剂量^131I治疗青少年Graves,病的疗效。方法均采用^131I治疗,每克甲状腺组织给^131I为1480—2220kBq,并结合患者年龄、甲状腺质量、病程、是否曾用过抗甲状腺药物治疗等进行综合考虑确定^131I治疗剂量。参照对^131I治疗后疗效评价标准,将治疗结果分为完全缓解(包括甲状腺功能正常和甲状腺功能减退)、显效、部分缓解、无效。结果85例患者中,一次治疗完全缓解41例,显效34例,部分缓解10例,无效为0,总有效率为100%。结论小剂量^131I是治疗青少年Graves’病有效、简便、安全的方法,重复治疗可以提高Graves’病的治愈率,不会明显增加甲状腺功能减退的发生率。 Objective To observe the the curative effects in younger with Graves disease therapied by ^131I. Methods The dose of ^131I is administrated with 1480-2220kBq/g of thyroid tissue which was decided by many factors that include the paticnt's Age, volume of thyroid, course and if antihyroid drug is administrated. The curative effects was classfide into four groups: complete remission, excellence, parts of remission, no effect. Results 47 were complete remission, 34 were excellence, 10 were the parts of remission and 0 was no effects. The total effective power was 100%. Conclusions Therapy with low-dose of ^131I for younger with Graves' disease is an effect, simple and safe method. Repeating treatment with ^131I will improve the curative rate of Graves ' disease in younger, and the incidence of hypothyroidism cannot be increased.
出处 《国际放射医学核医学杂志》 2007年第4期226-228,共3页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 格雷夫斯病 碘放射性同位素 放射疗法 抗甲状腺药 Graves' disease Idine isotopes Radiotherapy Antithyroid drug
  • 相关文献

参考文献5

  • 1秦岚 尹乐等.^133I治疗青少年甲亢的疗效观察[J].中国青年核医学论坛,2003,3(1):28-29.
  • 2张承刚.放射性^133I治疗甲状腺功能亢进症的方法学.见:张承刚主编.甲状腺疾病核素治疗学.第一版,北京:原子能出版社.2003.188-189.
  • 3王勤奋,李宝兰,张承刚.治疗甲状腺功能亢进症的疗效评价.见:张承刚主编.甲状腺疾病核素治疗学.第一版,北京:原子能出版社,2003.325-326.
  • 4段东,罗加,倪济苍,李建国,陈显煜.青少年甲亢^(131)I治疗的临床初探[J].重庆医科大学学报,2002,27(1):96-99. 被引量:15
  • 5徐海青,吴边.^(131)I合并小剂量碳酸锂治疗Graves病的临床探讨[J].国际放射医学核医学杂志,2006,30(3):151-152. 被引量:4

二级参考文献10

  • 1覃伟武.^(131)碘治疗甲亢642例疗效观察[J].广西医学,1995,17(3):198-200. 被引量:3
  • 2马寄晓.^131I治疗甲状腺功能亢进症的远期观察[J].中华核医学杂志,1984,4(1):7-11.
  • 3谭天秩.放射性核素治疗.临床核医学.第二版.北京:人民卫生出版社,1993,1218—1231.
  • 4Bogazzi F, Bartalena L, Brogioni S, et al. Comparison of radioiodine with mdioiodine plus lithium in the treatment of Graves thperthyroidism.J Clin Endocrinol Metab, 1999, 84(2): 499-503.
  • 5Mazzaferri EL Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab,2001, 86(4): 1447-1463.
  • 6马寄晓.放射性核素治疗的现状与进展[J].中华核医学杂志,1984,4(1):1-3.
  • 7谭天秩.放射性核素治疗[A].见:中华人民共和国卫生部医政司主编.核医学诊断与治疗规范:第1版[C].北京:科学出版社,1997.280~302.
  • 8管昌田.^(131)I治疗甲亢的最佳化[J].国外医学(放射医学核医学分册),1997,21(5):252-256. 被引量:53
  • 9卢倜章.^(131)I治疗甲状腺疾病的研究趋向[J].国外医学(放射医学核医学分册),2000,24(3):97-100. 被引量:9
  • 10丁昊,匡安仁,管昌田.碳酸锂增强分化型甲状腺癌术后残留甲状腺^(131)I吸收剂量的研究[J].中华核医学杂志,2003,23(2):80-81. 被引量:9

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部